Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …

Background Upgrade rates of high-risk breast lesions after screening mammography were
examined. Methods The Breast Cancer Surveillance Consortium registry was used to …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

OBJECTIVE. The management of lobular neoplasia (LN) on percutaneous core breast
biopsies remains controversial. Published upgrade rates after surgical excision vary widely …

Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …

Background Management recommendations for lobular neoplasia (LN) including lobular
carcinoma-in-situ (LCIS) and atypical lobular hyperplasia (ALH) diagnosed in core biopsies …

Atypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions,
growing inside ducts and terminal ducto-lobular units. They represent a marker of increased …

Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …